311 related articles for article (PubMed ID: 11702203)
1. Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutations.
Chen JM; Montier T; Férec C
Hum Genet; 2001 Sep; 109(3):245-52. PubMed ID: 11702203
[TBL] [Abstract][Full Text] [Related]
2. A novel A121T mutation in human cationic trypsinogen associated with hereditary pancreatitis: functional data indicating a loss-of-function mutation influencing the R122 trypsin cleavage site.
Felderbauer P; Schnekenburger J; Lebert R; Bulut K; Parry M; Meister T; Schick V; Schmitz F; Domschke W; Schmidt WE
J Med Genet; 2008 Aug; 45(8):507-12. PubMed ID: 18511571
[TBL] [Abstract][Full Text] [Related]
3. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of hereditary pancreatitis.
Chen JM; Ferec C
Eur J Hum Genet; 2000 Jul; 8(7):473-9. PubMed ID: 10909845
[TBL] [Abstract][Full Text] [Related]
5. Gene conversion-like missense mutations in the human cationic trypsinogen gene and insights into the molecular evolution of the human trypsinogen family.
Chen JM; Ferec C
Mol Genet Metab; 2000 Nov; 71(3):463-9. PubMed ID: 11073713
[TBL] [Abstract][Full Text] [Related]
6. [Significance of trypsinogen gene mutations in the etiology of hereditary pancreatitis].
Sahin-Tóth M; Tóth M
Orv Hetil; 2001 Mar; 142(12):603-6. PubMed ID: 11324217
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel pancreatitis-associated missense mutation, R116C, in the human cationic trypsinogen gene (PRSS1).
Le Maréchal C; Bretagne JF; Raguénès O; Quéré I; Chen JM; Ferec C
Mol Genet Metab; 2001 Nov; 74(3):342-4. PubMed ID: 11708864
[TBL] [Abstract][Full Text] [Related]
8. The pathobiochemistry of hereditary pancreatitis: studies on recombinant human cationic trypsinogen.
Sahin-Tóth M
Pancreatology; 2001; 1(5):461-5. PubMed ID: 12120225
[TBL] [Abstract][Full Text] [Related]
9. Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography.
Le Maréchal C; Chen JM; Quéré I; Raguénès O; Férec C; Auroux J
BMC Genet; 2001; 2():19. PubMed ID: 11734061
[TBL] [Abstract][Full Text] [Related]
10. Trypsinogen stabilization by mutation Arg117-->His: a unifying pathomechanism for hereditary pancreatitis?
Sahin-Tóth M; Gráf L; Tóth M
Biochem Biophys Res Commun; 1999 Oct; 264(2):505-8. PubMed ID: 10529393
[TBL] [Abstract][Full Text] [Related]
11. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications.
Truninger K; Ammann RW; Blum HE; Witt H
Swiss Med Wkly; 2001 Oct; 131(39-40):565-74. PubMed ID: 11775491
[TBL] [Abstract][Full Text] [Related]
12. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen.
Sahin-Tóth M; Tóth M
Biochem Biophys Res Commun; 2000 Nov; 278(2):286-9. PubMed ID: 11097832
[TBL] [Abstract][Full Text] [Related]
13. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
[TBL] [Abstract][Full Text] [Related]
14. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the cationic trypsinogen in hereditary pancreatitis.
Teich N; Mössner J; Keim V
Hum Mutat; 1998; 12(1):39-43. PubMed ID: 9633818
[TBL] [Abstract][Full Text] [Related]
16. Evolution of trypsinogen activation peptides.
Chen JM; Kukor Z; Le Maréchal C; Tóth M; Tsakiris L; Raguénès O; Férec C; Sahin-Tóth M
Mol Biol Evol; 2003 Nov; 20(11):1767-77. PubMed ID: 12832630
[TBL] [Abstract][Full Text] [Related]
17. Cationic trypsinogen mutations and pancreatitis.
Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
Clin Lab Med; 2005 Mar; 25(1):39-59. PubMed ID: 15749231
[TBL] [Abstract][Full Text] [Related]
18. The course of genetically determined chronic pancreatitis.
Keim V; Witt H; Bauer N; Bodeker H; Rosendahl J; Teich N; Mossner J
JOP; 2003 Jul; 4(4):146-54. PubMed ID: 12853682
[TBL] [Abstract][Full Text] [Related]
19. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
Jancsó Z; Sahin-Tóth M
J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
[TBL] [Abstract][Full Text] [Related]
20. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen.
Simon P; Weiss FU; Sahin-Toth M; Parry M; Nayler O; Lenfers B; Schnekenburger J; Mayerle J; Domschke W; Lerch MM
J Biol Chem; 2002 Feb; 277(7):5404-10. PubMed ID: 11719509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
